Gamma Biosciences and Mirus Bio to Develop Lipid-Polymer Nanocomplexes

Gamma Biosciences has announced an initiative through its subsidiary, Mirus Bio, to develop lipid-polymer nanocomplexes for improve mRNA delivery solutions.